By: Benzinga
February 18, 2013 at 19:45 PM EST
Osiris Therapeutics Concludes Successful Defense of Stem Cell Patent Challenge in Australia
Osiris Therapeutics (NASDAQ: OSIR ) announced today the successful conclusion of a patent challenge in Australia by an opponent whose identity under Australian law was not disclosed. The patent at issue covers the
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Six Financial
Postage Rates Bots go here